The Business Cocktail
Mar 21, 2019
Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV)...
Read MoreAnticoagulants (VTE & AF) Therapeutics Market
May 31, 2016
The Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 ...
Read MoreGlobal atrial fibrillation market is expected to grow to $12.5 billion by 2020
May 12, 2016
Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which ar...
Read MoreGlobal VTE market is expected to grow to $4.75 billion by 2020
May 11, 2016
Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE market was $4.2 billion in 2015 and ...
Read MoreAnticoagulants-Market Insights; Drugs Sales Forecast (VTE & AF)
May 10, 2016
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 202...
Read MoreA Glimpse of the Anticoagulants Therapy Market; Major Players
Apr 21, 2015
VTE therapeutics & Atrial Fibrillation market was worth USD 4 billion in 2014 and USD 7.86 billion respectively. The VTE therapeutic market is expected to reach US...
Read MoreAnticoagulants Market A Big Boom
Apr 2, 2015
Analyze Anticoagulants Market with DelveInsight Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. They c...
Read More
